Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.

Richard Greil; Lisa Pleyer; Bettina Jansko; Carmen Feierabend; Lukas Rettenbacher; Olga Stiefel; Christoph Rass; Patrick Morre; Daniel Neureiter; Sigrun Greil-Ressler

doi:10.18632/oncotarget.25037

Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.

Richard Greil^* (First author), Lisa Pleyer (Co-author), Bettina Jansko, Carmen Feierabend, Lukas Rettenbacher (Co-author), Olga Stiefel, Christoph Rass (Co-author), Patrick Morre (Co-author), Daniel Neureiter (Co-author), Sigrun Greil-Ressler

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

Original language	English
Pages (from-to)	20928-20940
Journal	Oncotarget
Volume	9
Issue number	29
DOIs	https://doi.org/10.18632/oncotarget.25037
Publication status	Published - 2018

Access to Document

10.18632/oncotarget.25037

Cite this

@article{8760fb8c73c24391a0fcee9ecc180607,

title = "Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.",

author = "Richard Greil and Lisa Pleyer and Bettina Jansko and Carmen Feierabend and Lukas Rettenbacher and Olga Stiefel and Christoph Rass and Patrick Morre and Daniel Neureiter and Sigrun Greil-Ressler",

note = "Greil, Pleyer, Jansko, Feierabend, Rass, Morre, Greil-Ressler: IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Disease and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; Rettenbacher: Department of Nuclear Medicine, Paracelsus Medical University, Salzburg, Austria; Stiefel: Ordensklinikum Linz, Linz, Austria; Neureiter: Institute of Pathology, Paracelsus Medical University, Salzburg, Austria",

year = "2018",

doi = "10.18632/oncotarget.25037",

language = "English",

volume = "9",

pages = "20928--20940",

journal = "Oncotarget",

issn = "1949-2553",

number = "29",

}

TY - JOUR

T1 - Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.

AU - Greil, Richard

AU - Pleyer, Lisa

AU - Jansko, Bettina

AU - Feierabend, Carmen

AU - Rettenbacher, Lukas

AU - Stiefel, Olga

AU - Rass, Christoph

AU - Morre, Patrick

AU - Neureiter, Daniel

AU - Greil-Ressler, Sigrun

N1 - Greil, Pleyer, Jansko, Feierabend, Rass, Morre, Greil-Ressler: IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Disease and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; Rettenbacher: Department of Nuclear Medicine, Paracelsus Medical University, Salzburg, Austria; Stiefel: Ordensklinikum Linz, Linz, Austria; Neureiter: Institute of Pathology, Paracelsus Medical University, Salzburg, Austria

PY - 2018

Y1 - 2018

U2 - 10.18632/oncotarget.25037

DO - 10.18632/oncotarget.25037

M3 - Original Article

C2 - 29755699

SN - 1949-2553

VL - 9

SP - 20928

EP - 20940

JO - Oncotarget

JF - Oncotarget

IS - 29

ER -